Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

558 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interleukin-6 receptor antibodies (tocilizumab) in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (DOBERMANN-T): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.
Kunkel JB, Holle SLD, Hassager C, Pecini R, Wiberg S, Palm P, Holmvang L, Bang LE, Kjærgaard J, Thomsen JH, Engstrøm T, Møller JE, Lønborg JT, Frydland M, Søholm H. Kunkel JB, et al. Among authors: kjaergaard j. Trials. 2024 Nov 5;25(1):739. doi: 10.1186/s13063-024-08573-0. Trials. 2024. PMID: 39501388 Free PMC article.
Endothelial Dysfunction in Resuscitated Cardiac Arrest (ENDO-RCA): safety and efficacy of low-dose prostacyclin administration and blood pressure target in addition to standard therapy, as compared to standard therapy alone, in post-cardiac arrest syndrome patients: study protocol for a randomized controlled trial.
Meyer AS, Ostrowski SR, Kjaergaard J, Johansson PI, Hassager C. Meyer AS, et al. Among authors: kjaergaard j. Trials. 2016 Aug 2;17:378. doi: 10.1186/s13063-016-1477-z. Trials. 2016. PMID: 27484224 Free PMC article. Clinical Trial.
Risk factors of late cardiogenic shock and mortality in ST-segment elevation myocardial infarction patients.
Obling L, Frydland M, Hansen R, Møller-Helgestad OK, Lindholm MG, Holmvang L, Ravn HB, Wiberg S, Thomsen JH, Jensen LO, Kjærgaard J, Møller JE, Hassager C. Obling L, et al. Among authors: kjaergaard j. Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):7-15. doi: 10.1177/2048872617706503. Epub 2017 Apr 28. Eur Heart J Acute Cardiovasc Care. 2018. PMID: 28452562
Admission Leukocyte Count is Associated with Late Cardiogenic Shock Development and All-Cause 30-Day Mortality in Patients with St-Elevation Myocardial Infarction.
Klein A, Wiberg S, Hassager C, Winther-Jensen M, Frikke-Schmidt R, Bang LE, Lindholm MG, Holmvang L, Moeller-Helgestad O, Ravn HB, Jensen LO, Kjaergaard J, Moeller JE, Frydland M. Klein A, et al. Among authors: kjaergaard j. Shock. 2020 Mar;53(3):299-306. doi: 10.1097/SHK.0000000000001369. Shock. 2020. PMID: 31058719
Biomarkers predictive of late cardiogenic shock development in patients with suspected ST-elevation myocardial infarction.
Frydland M, Møller JE, Lindholm MG, Hansen R, Wiberg S, Lerche Helgestad OK, Thomsen JH, Goetze JP, Engstrøm T, Frikke-Schmidt R, Ravn HB, Holmvang L, Jensen LO, Kjaergaard J, Hassager C. Frydland M, et al. Among authors: kjaergaard j. Eur Heart J Acute Cardiovasc Care. 2020 Sep;9(6):557-566. doi: 10.1177/2048872619896063. Epub 2020 Jan 21. Eur Heart J Acute Cardiovasc Care. 2020. PMID: 31961195
Treatment Effects of Interleukin-6 Receptor Antibodies for Modulating the Systemic Inflammatory Response After Out-of-Hospital Cardiac Arrest (The IMICA Trial): A Double-Blinded, Placebo-Controlled, Single-Center, Randomized, Clinical Trial.
Meyer MAS, Wiberg S, Grand J, Meyer ASP, Obling LER, Frydland M, Thomsen JH, Josiassen J, Møller JE, Kjaergaard J, Hassager C. Meyer MAS, et al. Among authors: kjaergaard j. Circulation. 2021 May 11;143(19):1841-1851. doi: 10.1161/CIRCULATIONAHA.120.053318. Epub 2021 Mar 22. Circulation. 2021. PMID: 33745292 Free PMC article. Clinical Trial.
558 results